Diabetes

Autoimmune Diabetes

Submit Abstract Register Now

When defined as the phenotype of type 2 diabetes in combination with adult latent autoimmune diabetes islet antibody, the prevalence of LADA is approximately 10% of diabetic patients aged 40-75 years (16). Similar prevalence is found in non-insulin-dependent patients aged 35 years and older who have been diagnosed with phenotypic type 2 diabetes (17). Mortality from all causes was improved by 50% in LADA patients compared to non-diabetic patients, consistent with the results observed across the group of adult autoimmune diabetes. In addition, we show that the additional risk of death applies to deaths from men and women, especially from IHD. The reason for LADA is the proliferation of autoantibodies to pancreatic cells, insulin, or enzymes involved in the role of the pancreas. Antibodies that affect the pancreas and its function can affect the body's response to blood sugar levels.